Lague, Maricel B.

HRN: 06-93-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
CEFUROXIME 500MG (TAB)
04/29/2022
05/06/2022
PO
500mg
BID X 7 Days
Post-partum Prophylaxis-home Delivery; WBC: 20.5
Waiting Final Action 
05/03/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/03/2022
05/09/2022
IVTT
4.5g Then 2.25
Q6
CAP;
Waiting Final Action 
05/07/2022
CO-AMOXICLAV 625MG (TAB)
05/07/2022
05/13/2022
PO
625mg
Q8
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: